These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin. Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335 [TBL] [Abstract][Full Text] [Related]
3. Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease. Ferro BE; van Ingen J; Wattenberg M; van Soolingen D; Mouton JW J Antimicrob Chemother; 2015 Oct; 70(10):2838-43. PubMed ID: 26142475 [TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of the new macrolide A-56268 against mycobacteria. Berlin OG; Young LS; Floyd-Reising SA; Bruckner DA Eur J Clin Microbiol; 1987 Aug; 6(4):486-7. PubMed ID: 2959472 [No Abstract] [Full Text] [Related]
5. [In vitro sensitivity of Mycobacterium avium and Mycobacterium xenopi to erythromycin, roxithromycin and doxycycline]. Maugein J; Fourche J; Mormede M; Pellegrin JL Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):565-7. PubMed ID: 2797881 [TBL] [Abstract][Full Text] [Related]
6. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice]. Tomioka H; Sato K; Saito H Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119 [TBL] [Abstract][Full Text] [Related]
7. Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin. Doucet-Populaire F; Truffot-Pernot C; Grosset J; Jarlier V J Antimicrob Chemother; 1995 Jul; 36(1):129-36. PubMed ID: 8537260 [TBL] [Abstract][Full Text] [Related]
8. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM]. Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941 [TBL] [Abstract][Full Text] [Related]
9. Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Goldman RC; Zakula D; Flamm R; Beyer J; Capobianco J Antimicrob Agents Chemother; 1994 Jul; 38(7):1496-500. PubMed ID: 7979278 [TBL] [Abstract][Full Text] [Related]
10. The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study. Hosono Y; Kitada S; Yano Y; Mori M; Miki K; Miki M; Yoshimura K; Kagawa H; Oshitani Y; Yokota S J Infect Chemother; 2018 May; 24(5):353-357. PubMed ID: 29361415 [TBL] [Abstract][Full Text] [Related]
11. The macrolides: erythromycin, clarithromycin, and azithromycin. Alvarez-Elcoro S; Enzler MJ Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939 [TBL] [Abstract][Full Text] [Related]
12. Discovery of 2-phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate. Cernicchi G; Rampacci E; Massari S; Manfroni G; Barreca ML; Tabarrini O; Cecchetti V; Felicetti T; Di Luca M; Poma NV; Tavanti A; Passamonti F; Rindi L; Sabatini S Arch Pharm (Weinheim); 2024 Oct; 357(10):e2400296. PubMed ID: 38923553 [TBL] [Abstract][Full Text] [Related]
13. Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis. Rodrigues L; Wagner D; Viveiros M; Sampaio D; Couto I; Vavra M; Kern WV; Amaral L J Antimicrob Chemother; 2008 May; 61(5):1076-82. PubMed ID: 18310137 [TBL] [Abstract][Full Text] [Related]
14. Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex. Rastogi N; Labrousse V Antimicrob Agents Chemother; 1991 Mar; 35(3):462-70. PubMed ID: 1828135 [TBL] [Abstract][Full Text] [Related]
15. Erythromycin, roxithromycin, and clarithromycin: use of slow-binding kinetics to compare their in vitro interaction with a bacterial ribosomal complex active in peptide bond formation. Dinos GP; Connell SR; Nierhaus KH; Kalpaxis DL Mol Pharmacol; 2003 Mar; 63(3):617-23. PubMed ID: 12606769 [TBL] [Abstract][Full Text] [Related]
16. Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin. Matsiota-Bernard P; Zinzendorf N; Onody C; Guenounou M J Infect; 2000 Jan; 40(1):49-54. PubMed ID: 10762111 [TBL] [Abstract][Full Text] [Related]
17. Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteria. Danelishvili L; Wu M; Young LS; Bermudez LE Antimicrob Agents Chemother; 2005 Sep; 49(9):3707-14. PubMed ID: 16127044 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Etest for rapid susceptibility testing of Mycobacterium avium to clarithromycin. Lebrun L; Onody C; Vincent V; Nordmann P J Antimicrob Chemother; 1996 May; 37(5):999-1003. PubMed ID: 8737150 [TBL] [Abstract][Full Text] [Related]
19. Long term treatment with clarithromycin for cryptosporidiosis and emergence of drug resistant disseminated infection due to Mycobacterium avium: case report. Matteelli A; Signorini L; Tebaldi A; Bombana E; Chatel G; Pinsi G J Chemother; 1998 Dec; 10(6):474-5. PubMed ID: 9876056 [TBL] [Abstract][Full Text] [Related]